PRAME Is a Potential Carcinogenic Biomarker that Correlates with Patient Prognosis and Tumor Immunity Based on Pan-Cancer Analysis.

Zhao, Qi; Zhang, Zhongwei; Wu, Yinfang

Zhao, Qi; Zhang, Zhongwei; Wu, Yinfang.

Afiliação

Zhao Q; Department of Minimally Invasive Surgery, Shaoxing Second Hospital, Shaoxing, Zhejiang, China.
Zhang Z; Department of Gastrointestinal Surgery, Shaoxing Second Hospital, Shaoxing, Zhejiang, China.
Wu Y; Department of Gastrointestinal Surgery, Shaoxing Second Hospital, Shaoxing, Zhejiang, China moceng336@163.com.

Ann Clin Lab Sci ; 52(2): 185-195, 2022 Mar.

Article em En | MEDLINE | ID: mdl-35414497

Assuntos

Carcinógenos; Neoplasias; Antígenos de Neoplasias/genética; Biomarcadores Tumorais/genética; Carcinogênese/genética; Humanos; Neoplasias/metabolismo; Prognóstico; Microambiente Tumoral/genética

Palavras-chave

PRAME; carcinogenic biomarker; pan-cancer; prognosis; tumor immunity

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinógenos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links